The United Arab Emirates, the first foreign country to approve a Covid-19 vaccine developed by Chinese state-owned pharmaceutical group Sinopharm, said it had 86 per cent efficacy, according to interim results of a phase 3 trial.
The announcement is a boost for Beijing’s ambitions to establish its pharmaceutical companies as global leaders in developing and distributing vaccines and comes after the release of final stage results from western frontrunners Pfizer/BioNTech, Moderna and AstraZeneca/Oxford.
Chinese developers were forced to carry out phase 3 trials overseas because the virus is now almost fully under control in China.
您已閱讀23%（635字），剩余77%（2110字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。